This study is checking the long-term safety and effectiveness of the drug ublituximab for people with relapsing multiple sclerosis (RMS). It is open to 1100 people who have already completed one of the earlier, shorter studies of this drug. The main goal is to see how well the dr…
Phase: PHASE3 • Sponsor: TG Therapeutics, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC